We are live on ! Find out more
AFA

Abacus FCF Advisors Portfolio holdings

AUM $444M
1-Year Est. Return 44.44%
This Fund
S&P 500
This Quarter Est. Return
+10.95%
1 Year Est. Return
+44.44%
3 Year Est. Return
+142.32%
5 Year Est. Return
+208.76%
10 Year Est. Return
AUM
$431M
AUM Growth
+$28.8M
Cap. Flow
-$3.05M
Cap. Flow %
-0.71%
Top 10 Hldgs %
24.84%
Holding
175
New
25
Increased
35
Reduced
60
Closed
30

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$9.26M
2
LOW icon
Lowe's Companies
LOW
+$4.93M
3
AMGN icon
Amgen
AMGN
+$4.15M
4
PG icon
Procter & Gamble
PG
+$4.1M
5
LMT icon
Lockheed Martin
LMT
+$3.77M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$4.86M
2
AMAT icon
Applied Materials
AMAT
+$4.45M
3
TTD icon
Trade Desk
TTD
+$3.37M
4
MRK icon
Merck
MRK
+$3.27M
5
DECK icon
Deckers Outdoor
DECK
+$3.19M

Sector Composition

Rank Sector Weight
1 Technology 37.43%
2 Healthcare 13.56%
3 Consumer Discretionary 13.46%
4 Industrials 10.34%
5 Financials 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDW icon
76
CDW
CDW
$18.9B
$2.21M 0.51%
+9,745
New +$2.16M
MEDP icon
77
Medpace
MEDP
$16.3B
$2.19M 0.51%
6,552
-3,221
-33% -$1.22M
CPAY icon
78
Corpay
CPAY
$25.7B
$2.16M 0.5%
+6,918
New +$2.03M
PWR icon
79
Quanta Services
PWR
$84.2B
$2.07M 0.48%
+6,941
New +$1.84M
WSO icon
80
Watsco Inc
WSO
$13.2B
$2.06M 0.48%
4,188
+1,599
+62% +$769K
VRSN icon
81
VeriSign
VRSN
$26.3B
$2.04M 0.47%
+10,739
New +$1.94M
APAM icon
82
Artisan Partners
APAM
$2.86B
$2.03M 0.47%
46,917
+2
+0% +$83
EME icon
83
Emcor
EME
$29.9B
$2.03M 0.47%
4,708
ROL icon
84
Rollins
ROL
$18.6B
$1.94M 0.45%
38,387
+1,039
+3% +$51.3K
MCHP icon
85
Microchip Technology
MCHP
$38.8B
$1.92M 0.44%
23,894
-3,472
-13% -$287K
BRBR icon
86
BellRing Brands
BRBR
$1.55B
$1.85M 0.43%
30,469
-7,600
-20% -$422K
EXPO icon
87
Exponent
EXPO
$3.19B
$1.85M 0.43%
16,020
-2,581
-14% -$270K
AMP icon
88
Ameriprise Financial
AMP
$47.8B
$1.84M 0.43%
3,913
-3,912
-50% -$1.7M
TEAM icon
89
Atlassian
TEAM
$26.5B
$1.82M 0.42%
11,462
+2
+0% +$329
WDAY icon
90
Workday
WDAY
$41.5B
$1.8M 0.42%
7,374
CLX icon
91
Clorox
CLX
$12B
$1.79M 0.42%
11,014
NTNX icon
92
Nutanix
NTNX
$16.1B
$1.79M 0.41%
30,194
WHD icon
93
Cactus
WHD
$3.63B
$1.78M 0.41%
29,914
-11,195
-27% -$651K
RMD icon
94
ResMed
RMD
$31.1B
$1.77M 0.41%
+7,259
New +$1.62M
FDS icon
95
Factset
FDS
$10B
$1.75M 0.41%
+3,803
New +$1.62M
CART icon
96
Maplebear
CART
$10.7B
$1.67M 0.39%
+41,034
New +$1.44M
DCI icon
97
Donaldson
DCI
$10.7B
$1.65M 0.38%
22,443
JKHY icon
98
Jack Henry & Associates
JKHY
$11.4B
$1.61M 0.37%
9,130
+1,132
+14% +$192K
FAST icon
99
Fastenal
FAST
$54.8B
$1.59M 0.37%
44,418
-17,846
-29% -$604K
GEN icon
100
Gen Digital
GEN
$16.5B
$1.58M 0.37%
57,523
+7,591
+15% +$195K

Similar funds

Abacus FCF Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Abacus FCF Advisors held 175 positions worth $431M, up 7.2% from $402M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Abacus FCF Advisors's Q3 2024 filing shows 25 new, 35 increased, 60 reduced and 30 closed positions. Its largest new stake was Johnson & Johnson: 58,146 shares worth $9.42M. The largest sale was Meta Platforms (Facebook), an estimated $4.86M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 39% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Abacus FCF Advisors's largest Q3 2024 buy was Johnson & Johnson: 58,146 shares worth $9.42M.
  • Abacus FCF Advisors added most to Procter & Gamble in Q3 2024, an estimated $4.1M increase.
  • Abacus FCF Advisors's biggest Q3 2024 reduction was Meta Platforms (Facebook), cutting an estimated $4.86M.
  • Abacus FCF Advisors fully exited Applied Materials in Q3 2024, selling an estimated $4.45M.
  • Abacus FCF Advisors's ten largest holdings make up 25% of its $431M portfolio in Q3 2024.
  • Abacus FCF Advisors opened 25 new positions and closed 30 in Q3 2024.
  • Abacus FCF Advisors's portfolio value rose 7.2% quarter-over-quarter to $431M.

Based on Abacus FCF Advisors's 13F filing for Q3 2024, filed 8 Oct 2024.